Buy Symbicort Inhaler Online

Symbicort is a combination maintenance inhaler used for asthma and chronic obstructive pulmonary disease, or COPD. It contains budesonide and formoterol fumarate dihydrate, and it can be ordered with the dose or strength shown during checkout matched to your clinician’s directions. BorderFreeHealth helps U.S. customers access regulated pharmacy supply channels with US delivery from Canada.

The Symbicort inhaler is intended for regular controller therapy, not for sudden breathing distress. It combines an inhaled corticosteroid, which reduces airway inflammation over time, with a long-acting bronchodilator, which helps relax airway muscles. Choosing the correct strength, using the inhaler consistently, and keeping a rescue inhaler available for urgent symptoms are all important parts of safe treatment.

Symbicort Price, Strength Selection, and Ordering

Symbicort price can vary by strength, quantity, and whether a brand or budesonide formoterol alternative is selected. Current pricing is shown during ordering so you can match the inhaler strength and quantity to the treatment plan already discussed with your healthcare professional. Many people also consider the Symbicort inhaler cost when planning maintenance therapy, especially if they pay cash or have limited drug coverage.

Commonly referenced strengths include Symbicort 80/4.5 inhaler and Symbicort 160/4.5 inhaler, with the numbers reflecting the budesonide and formoterol amounts per actuation. The right strength depends on the condition being treated, age, symptom control, prior therapy, and safety factors. Do not choose a higher strength to try to improve symptoms faster; controller inhalers work best when used exactly as directed.

Patients comparing Symbicort cost with budesonide formoterol price should pay attention to active ingredients, strength, device format, and dosing instructions. A lower cash price is only useful when the inhaler is clinically appropriate and you understand how to use it correctly. If your regimen changes, ask your clinician or pharmacist to review the device steps before the first dose.

What Symbicort Treats

Symbicort is used as maintenance treatment for asthma in patients who need both an inhaled corticosteroid and a long-acting beta2-agonist. It is also used as maintenance treatment for COPD, including chronic bronchitis and emphysema, to help improve airflow and reduce exacerbation risk. For broader background on airway inflammation, triggers, and long-term control, see our condition information on asthma and chronic obstructive pulmonary disease.

Symbicort is not a rescue inhaler for acute bronchospasm or severe sudden shortness of breath. A fast-acting reliever such as albuterol is typically used for immediate symptoms when it is part of the patient’s action plan. If breathing worsens quickly, symptoms do not respond to rescue treatment, or lips or fingernails look blue, seek urgent medical help.

Why it matters: A controller inhaler and a rescue inhaler serve different roles, even when both can improve breathing.

Active Ingredients and How They Work

Symbicort contains budesonide and formoterol fumarate dihydrate. Budesonide is an inhaled corticosteroid, often shortened to ICS, that helps reduce swelling and irritation inside the airways. Formoterol is a long-acting beta2-agonist, or LABA, that relaxes airway smooth muscle and helps keep airways open for many hours.

Because Symbicort includes a steroid component, it is considered a steroid inhaler, but it is not the same as taking oral steroid tablets. Inhaled corticosteroids deliver medicine directly to the lungs, which can reduce whole-body exposure compared with systemic steroids. Even so, long-term or high-dose use may still require monitoring for steroid-related effects.

The two medicines support different parts of airway control. Budesonide targets inflammation that contributes to recurring symptoms and flares. Formoterol helps reduce airway tightening. Together, they can help improve daily control when used as a scheduled maintenance inhaler.

How to Use the Inhaler

Use Symbicort exactly as directed by your healthcare professional and the product label. Many adult regimens use two inhalations twice daily, but dosing can differ by diagnosis, age, strength, and treatment plan. Do not increase the number of inhalations or use extra maintenance doses unless a clinician specifically instructs you to do so.

General metered-dose inhaler technique starts with shaking the inhaler, breathing out fully, sealing your lips around the mouthpiece, beginning a slow deep breath, pressing the canister, and continuing to inhale. Hold your breath for about 10 seconds if comfortable, then breathe out slowly. If a second inhalation is part of your directions, wait as instructed before repeating the steps.

Rinse your mouth with water and spit after each use. This lowers the chance of oral thrush, a yeast infection that can cause white patches, soreness, or taste changes. Prime the inhaler before first use and after periods without use according to the label, and track remaining doses with the counter when present.

Quick tip: Keep the inhaler cap closed between uses so the mouthpiece stays clean.

Missed Dose and Daily Routine

If you miss a scheduled dose, follow the instructions provided with your medication or ask a healthcare professional for individualized guidance. In many maintenance-inhaler routines, the missed dose is taken when remembered unless it is close to the next scheduled dose. Doubling doses can increase the chance of tremor, palpitations, or other side effects.

A consistent morning and evening routine can make controller therapy easier to remember. Some people link inhaler use with toothbrushing, a phone reminder, or a medication app. If missed doses happen often, bring that pattern up during a visit because device type, timing, or treatment complexity may need review.

Storage, Handling, and Travel

Store the inhaler at room temperature, away from excessive heat, open flame, and direct sunlight. Do not puncture, crush, or burn the canister, even when it appears empty. Keep the mouthpiece clean and dry, and avoid washing or soaking the metal canister unless the manufacturer’s instructions specifically allow it.

Carry the inhaler in hand luggage when traveling so it remains accessible and protected from extreme temperatures. A copy of the medication label can help if questions arise at airport screening or during travel. Country-of-origin details may vary by supply, and related information is available under Canada-sourced products.

Orders may use prompt, express shipping when relevant to the shipment. Once received, inspect the inhaler, packaging, and dose counter before use. Contact a healthcare professional or pharmacist if the device appears damaged, the counter does not move, or spray performance changes unexpectedly.

Side Effects, Warnings, and Monitoring

Common Symbicort side effects can include throat irritation, hoarseness, cough, headache, upper respiratory symptoms, tremor, nausea, or palpitations. Oral thrush may occur because of the inhaled corticosteroid component, which is why rinsing and spitting after each dose is important. Some effects improve as technique and routine become more consistent, but persistent or bothersome symptoms should be discussed with a clinician.

Serious reactions are less common but need prompt attention. Seek urgent care for paradoxical bronchospasm, which is sudden wheezing or breathing difficulty right after inhalation, or for signs of a severe allergic reaction such as swelling of the face, lips, tongue, or throat. People with COPD should know that inhaled corticosteroids may be associated with an increased risk of pneumonia.

Long-term corticosteroid exposure may affect adrenal function, bones, eyes, growth in children, or infection risk. LABA medicines can affect heart rate, blood pressure, and rhythm in susceptible patients. Monitoring may be especially important for people with glaucoma, cataracts, osteoporosis, diabetes, thyroid disease, seizure disorders, arrhythmias, uncontrolled high blood pressure, or frequent infections.

Symbicort should not be combined with another long-acting beta-agonist unless specifically directed by a healthcare professional. Strong CYP3A4 inhibitors, including certain antifungal or antiviral medicines, can increase budesonide exposure. Beta-blockers may reduce bronchodilator effect, while some diuretics, monoamine oxidase inhibitors, or tricyclic antidepressants can increase cardiovascular concerns. Always keep an updated medication list, including non-prescription products and supplements.

Who Should Use Extra Caution

Symbicort may not be appropriate for people with severe hypersensitivity to budesonide, formoterol, or any component of the inhaler. It should not be started during a rapidly deteriorating asthma or COPD episode unless directed in an urgent-care setting. Patients with active or untreated infections should discuss timing and risk because corticosteroids can affect immune response.

Children, older adults, pregnant patients, and people with multiple chronic conditions may need closer monitoring. In children, clinicians may monitor growth when inhaled corticosteroids are used over time. In older adults, the balance between symptom control, pneumonia risk, bone health, and heart rhythm concerns may require periodic reassessment.

If symptoms remain uncontrolled despite regular use, the answer is not simply to use more inhalations. Poor inhaler technique, ongoing exposure to smoke or allergens, under-treated inflammation, medication interactions, or a need for a different class may be involved. A written asthma or COPD action plan can clarify what to do when symptoms change.

Symbicort and Albuterol

Symbicort and albuterol are different types of inhalers. Symbicort is a maintenance controller that contains budesonide and formoterol. Albuterol is a short-acting beta2-agonist, often called a rescue inhaler, that acts quickly to relieve sudden bronchospasm. Many patients use both types, but each has a distinct role.

Do not replace your rescue inhaler with Symbicort unless your clinician has given a specific plan that says so. Some asthma strategies use budesonide-formoterol in specialized ways, but that approach depends on diagnosis, age, local labeling, and clinician direction. For routine product selection, treat Symbicort as a controller inhaler and keep rescue instructions clear.

Benefits of a Combination Controller

A single inhaler that combines an ICS and LABA can simplify treatment for people who need both components. Fewer separate devices may improve routine consistency and reduce confusion about which inhaler is used daily. Consistent use may help reduce daytime symptoms, nighttime awakenings, activity limitations, and flare risk in appropriate patients.

The dose counter and familiar pressurized metered-dose format can also support adherence. Technique still matters: a poorly timed breath or shallow inhalation can reduce lung delivery. If using the device feels difficult, ask whether a spacer, technique demonstration, or different inhaler type would be suitable.

Comparing Related Respiratory Treatments

Respiratory maintenance therapy is individualized. Other inhaled corticosteroid and long-acting bronchodilator combinations may be considered when device preference, dosing schedule, side effects, or response differs. COPD patients may sometimes use a long-acting muscarinic antagonist, or LAMA, with or without an inhaled corticosteroid depending on symptoms and exacerbation history.

Patients looking for a Symbicort equivalent should compare active ingredients, strength, device, dosing schedule, and approved use rather than relying on name similarity. Budesonide formoterol products may share the same active ingredients, but substitution decisions should be clinically guided. Browse the respiratory category for related inhaler and airway-treatment options, and see our respiratory articles for additional treatment context.

What to Discuss With a Healthcare Professional

• Which Symbicort strength matches your diagnosis and symptom pattern
• How often to reassess lung control and inhaler technique
• Which symptoms should trigger rescue inhaler use or urgent care
• Whether eye, bone, infection, or adrenal monitoring is needed
• How current medicines may interact with budesonide or formoterol
• Whether smoking, allergens, work exposures, or exercise affect control
• When stepping up, stepping down, or switching therapy may be considered

Authoritative Sources

Official prescribing information

FDA DailyMed label

Health Canada product record

This content is for informational purposes only and is not a substitute for professional medical advice.